Results 11,161-11,180 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: The Chairman will give me some latitude because of that.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: I thank the Chairman. I welcome the witnesses. I will articulate my usual opening clause. Sometimes I can be abrupt because I only have ten minutes. It is nothing personal. I refer to earlier questioning of Mr. Barry. Is it correct that he is a non-executive director of PM Group?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Is the PM Group doing any work at all relevant to the hospital?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Has it any current or former professional relationship with BAM?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Is that on the private consultancy side?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Does Mr. Barry have knowledge of the nine cases that BAM is taking against arms of the State relevant to other projects?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Given Mr. Barry's experience of the NRA and his substantial international experience, if a company has form in litigating after the fact, does that come into consideration at tendering stage or assessment?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Mr. Barry said that he had been involved in a few disputes and, of course, these can happen in the building of any project, no matter how small or big.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: It is totally without prejudice but common sense demands that one would take a view.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: They are. Is it correct that one of the clauses refers to "most economically advantageous"?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: If builder A has sued me nine times previously, it will probably come into my consideration of what is economically most advantageous.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Why not?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: I would be very interested in a note on why we cannot take such matters into account. I know it is probably a deeper issue but Mr. Barry has unique experience in the area in which we are interested. Is Mr. Barry's relationship with BAM, whether on the State side or the private side, recent?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: What about the private side? I do not mean to pry but it is in the public interest.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Okay, that is fine. I welcome the Secretary General. He said that PwC consultants retain their independence but, as I said earlier, the contestants cannot judge the beauty pageant. By Mr. Breslin's admission PwC threw in a few extra lines at the end to reaffirm their genius in its advices of November or December in the report. Despite the great name and global standing of PwC, can Mr....
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: It is a matter of form that the practice should be not to do these things. I said at the previous meeting we had on this that while it is the prerogative of the Office of Comptroller and Auditor General to decline a request to do particular work, the one thing that we have with the office is absolute certainty that no commercial relationships exist. Was the high-level advice before...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: That is not a tender though.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: So it went out to tender. How much did PwC get for that? We know it received €450,000 for the later report but how much did it receive for the high-level input before Christmas?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: How much was the company paid?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: No, I made an observation, which I am entitled to do.